SNYR
Price
$4.49
Change
-$0.63 (-12.30%)
Updated
Dec 20, 04:59 PM (EDT)
ZYXI
Price
$8.28
Change
-$0.12 (-1.43%)
Updated
Dec 20, 04:59 PM (EDT)
67 days until earnings call
Ad is loading...

SNYR vs ZYXI

Header iconSNYR vs ZYXI Comparison
Open Charts SNYR vs ZYXIBanner chart's image
Synergy CHC
Price$4.49
Change-$0.63 (-12.30%)
Volume$100
CapitalizationN/A
Zynex
Price$8.28
Change-$0.12 (-1.43%)
Volume$11.04K
CapitalizationN/A
SNYR vs ZYXI Comparison Chart
Loading...
SNYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZYXI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SNYR vs. ZYXI commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SNYR is a Hold and ZYXI is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (SNYR: $4.50 vs. ZYXI: $8.25)
Brand notoriety: SNYR and ZYXI are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: SNYR: 92% vs. ZYXI: 346%
Market capitalization -- SNYR: $494.39K vs. ZYXI: $397.95M
SNYR [@Medical Distributors] is valued at $494.39K. ZYXI’s [@Medical Distributors] market capitalization is $397.95M. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $9.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SNYR’s FA Score shows that 1 FA rating(s) are green whileZYXI’s FA Score has 1 green FA rating(s).

  • SNYR’s FA Score: 1 green, 4 red.
  • ZYXI’s FA Score: 1 green, 4 red.
According to our system of comparison, SNYR is a better buy in the long-term than ZYXI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SNYR’s TA Score shows that 4 TA indicator(s) are bullish while ZYXI’s TA Score has 3 bullish TA indicator(s).

  • SNYR’s TA Score: 4 bullish, 5 bearish.
  • ZYXI’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, SNYR is a better buy in the short-term than ZYXI.

Price Growth

SNYR (@Medical Distributors) experienced а -14.61% price change this week, while ZYXI (@Medical Distributors) price change was +1.35% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +0.86%. For the same industry, the average monthly price growth was +2.51%, and the average quarterly price growth was +147.05%.

Reported Earning Dates

ZYXI is expected to report earnings on Feb 27, 2025.

Industries' Descriptions

@Medical Distributors (+0.86% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZYXI($398M) has a higher market cap than SNYR($494K). SNYR YTD gains are higher at: 3681.513 vs. ZYXI (-24.242). ZYXI has higher annual earnings (EBITDA): 17.9M vs. SNYR (-8.26M). ZYXI has more cash in the bank: 44.6M vs. SNYR (315K). SNYR has less debt than ZYXI: SNYR (5.8M) vs ZYXI (76.2M). ZYXI has higher revenues than SNYR: ZYXI (184M) vs SNYR (26M).
SNYRZYXISNYR / ZYXI
Capitalization494K398M0%
EBITDA-8.26M17.9M-46%
Gain YTD3681.513-24.242-15,186%
P/E RatioN/A46.30-
Revenue26M184M14%
Total Cash315K44.6M1%
Total Debt5.8M76.2M8%
FUNDAMENTALS RATINGS
SNYR vs ZYXI: Fundamental Ratings
SNYR
ZYXI
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
96
Overvalued
PROFIT vs RISK RATING
1..100
41100
SMR RATING
1..100
10069
PRICE GROWTH RATING
1..100
3456
P/E GROWTH RATING
1..100
297
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNYR's Valuation (65) in the null industry is in the same range as ZYXI (96) in the Medical Specialties industry. This means that SNYR’s stock grew similarly to ZYXI’s over the last 12 months.

SNYR's Profit vs Risk Rating (41) in the null industry is somewhat better than the same rating for ZYXI (100) in the Medical Specialties industry. This means that SNYR’s stock grew somewhat faster than ZYXI’s over the last 12 months.

ZYXI's SMR Rating (69) in the Medical Specialties industry is in the same range as SNYR (100) in the null industry. This means that ZYXI’s stock grew similarly to SNYR’s over the last 12 months.

SNYR's Price Growth Rating (34) in the null industry is in the same range as ZYXI (56) in the Medical Specialties industry. This means that SNYR’s stock grew similarly to ZYXI’s over the last 12 months.

ZYXI's P/E Growth Rating (7) in the Medical Specialties industry is in the same range as SNYR (29) in the null industry. This means that ZYXI’s stock grew similarly to SNYR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SNYRZYXI
RSI
ODDS (%)
Bullish Trend 3 days ago
75%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
81%
Momentum
ODDS (%)
Bearish Trend 3 days ago
65%
Bullish Trend 3 days ago
81%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
69%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
58%
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 27 days ago
71%
Bullish Trend 13 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 5 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 3 days ago
80%
View a ticker or compare two or three
Ad is loading...
SNYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZYXI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IDHIX19.420.23
+1.20%
Integrity Dividend Harvest I
FTQGX38.400.44
+1.16%
Fidelity Focused Stock
BASVX12.870.14
+1.10%
Brown Advisory Sustainable Val Inst
LLPFX24.210.24
+0.99%
Longleaf Partners
LOAGX13.92-0.01
-0.07%
Lord Abbett International Growth F3

SNYR and

Correlation & Price change

A.I.dvisor tells us that SNYR and COSM have been poorly correlated (+18% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNYR and COSM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNYR
1D Price
Change %
SNYR100%
-12.11%
COSM - SNYR
18%
Poorly correlated
-5.82%
ZYXI - SNYR
-2%
Poorly correlated
-1.79%

ZYXI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZYXI has been loosely correlated with OMI. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ZYXI jumps, then OMI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZYXI
1D Price
Change %
ZYXI100%
-1.79%
OMI - ZYXI
39%
Loosely correlated
-0.79%
HSIC - ZYXI
17%
Poorly correlated
+1.26%
PDCO - ZYXI
14%
Poorly correlated
-0.16%
COSM - ZYXI
11%
Poorly correlated
-5.82%
GEG - ZYXI
11%
Poorly correlated
+2.70%
More